Cargando…

SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus

SARS-CoV-2 is the most recent coronavirus which crossed the species barrier in 2019 and provoked a still ongoing and dangerous pandemic known as coronavirus disease 2019 (COVID-19). The SARS-CoV-2 infection has triggered an impressive amount of clinical and experimental studies to identify an effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iacob, Simona, Iacob, Diana Gabriela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479232/ https://www.ncbi.nlm.nih.gov/pubmed/32982720 http://dx.doi.org/10.3389/fphar.2020.01224

Ejemplares similares

Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment—Clinical Points of View and Practical Considerations
por: Iacob, Simona A., et al.
Publicado: (2017)

Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
por: Iacob, Simona, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown
por: Iacob, Simona Alexandra, et al.
Publicado: (2022)

Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats
por: Iacob, Simona, et al.
Publicado: (2019)

Eosinophilic Colitis and Clostridioides difficile Sepsis With Rapid Remission After Antimicrobial Treatment; A Rare Coincidence and Its Pathogenic Implications
por: Iacob, Simona Alexandra, et al.
Publicado: (2020)

Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis
por: Iacob, Diana Gabriela, et al.
Publicado: (2020)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
por: Verma, Surjeet, et al.
Publicado: (2020)

Parallel epidemics, or nearly so: Certainties and uncertainties about SARS-CoV-2 in Italy
por: Gentile, Sandro, et al.
Publicado: (2020)

Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy
por: Iacob, Simona A., et al.
Publicado: (2017)

Host and immunosuppression-related factors influencing fibrosis occurrence post liver transplantation
por: Iacob, Speranta, et al.
Publicado: (2022)

Liver fibrosis progression in a cohort of young HIV and HIV/ HBV co-infected patients: A longitudinal study using non-invasive APRI and Fib-4 scores
por: Iacob, Diana Gabriela, et al.
Publicado: (2022)

Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection
por: Al-Motawa, Maryam S., et al.
Publicado: (2020)

Editorial: Cell cycle control as a new therapeutic approach for SARS-CoV-2 infection
por: Rizzo, Roberta, et al.
Publicado: (2023)

An update on SARS-CoV-2 immunization and future directions
por: Rana, Rashmi, et al.
Publicado: (2023)

An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2
por: Bahramsoltani, Roodabeh, et al.
Publicado: (2020)

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
por: Zhong, Wu, et al.
Publicado: (2022)

Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
por: Campione, Elena, et al.
Publicado: (2021)

SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
por: Kanimozhi, G., et al.
Publicado: (2021)

LUNG ULTRASOUND IN NEONATES WITH COVID-19 PNEUMONIA – THE START OF A NEW ERA
por: Stoicescu, Emil - Robert, et al.
Publicado: (2022)

Pregnancy Outcomes in SARS-CoV-2-Positive Patients: A 20-Month Retrospective Analysis of Delivery Cases
por: Moza, Andreea, et al.
Publicado: (2023)

Outcome of Newborns with Confirmed or Possible SARS-CoV-2 Vertical Infection—A Scoping Review
por: Moza, Andreea, et al.
Publicado: (2023)

New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection
por: Yan, Shijia, et al.
Publicado: (2020)

Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing
por: Kern, Charlotte, et al.
Publicado: (2021)

Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
por: Chen, Wei, et al.
Publicado: (2021)

Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
por: Kim, Cheorl-Ho
Publicado: (2021)

Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients
por: Spuch, Carlos, et al.
Publicado: (2022)

Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs
por: Zhong, Wu, et al.
Publicado: (2022)

Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises
por: Satapathy, Prakasini, et al.
Publicado: (2022)

Commentary: An evaluation of traditional Persian medicine for the management of SARS-CoV-2
por: Mirhosseini, Haniye, et al.
Publicado: (2023)

Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches
por: Zareei, Sara, et al.
Publicado: (2022)

First Neonates with Vertical Transmission of SARS-CoV-2 Infection in Late Pregnancy in West Part of Romania: Case Series
por: Iacob, Daniela, et al.
Publicado: (2022)

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

Versatile β-Catenin Is Crucial for SARS-CoV-2 Infection
por: Chatterjee, Sanchari, et al.
Publicado: (2022)

BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?
por: Kamat, Siya, et al.
Publicado: (2020)

Mitochondria Targeted Viral Replication and Survival Strategies—Prospective on SARS-CoV-2
por: Gatti, Priya, et al.
Publicado: (2020)

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
por: Chen, Catherine Z., et al.
Publicado: (2021)

Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells
por: Raghavan, Somasundaram, et al.
Publicado: (2022)

Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
por: Liu, Xiao-Huan, et al.
Publicado: (2022)

Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection
por: Farooq, Mariya, et al.
Publicado: (2022)

Corrigendum: Commentary: An evaluation of traditional Persian medicine for the management of SARS-CoV-2
por: Mirhosseini, Haniye, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_goft78u9b195c4ujkopgepq1uo